Effect of Galcanezumab on Total Pain Burden in Patients Who Had Previously Not Benefited from Migraine Preventive Medication (CONQUER Trial): A Post Hoc Analysis

被引：0
|
作者：
Jessica Ailani
Jeffrey Scott Andrews
Antje Tockhorn-Heidenreich
Richard Wenzel
Mallikarjuna Rettiganti
机构：
[1] Medstar Georgetown University,
[2] Eli Lilly and Company,undefined
来源：
Advances in Therapy | 2022年 / 39卷
关键词：
CONQUER trial; Galcanezumab; Migraine; Prior preventive failures; Total pain burden;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
页码：4544 / 4555
页数：11
相关论文
共 50 条
  • [41] CHARACTERIZATION OF PATIENTS WHO HAD ≥5% WEIGHT LOSS WITH FT218 (ONCE-NIGHTLY SODIUM OXYBATE): POST HOC ANALYSIS FROM REST-ON
    Roth, Thomas
    Morse, Anne
    Bogan, Richard
    Roy, Asim
    Dubow, Jordan
    Gudeman, Jennifer
    Dauvilliers, Yves
    SLEEP, 2023, 46
  • [42] Who, if anyone, may benefit from a total hip arthroplasty after a displaced femoral neck fracture? A POST HOC SUBGRO UP ANALYSIS OF THE HEALTH TRIAL
    Frihagen, F.
    Comeau-Gauthier, M.
    Axelrod, D.
    Bzovsky, S.
    Poolman, R.
    Heels-Ansdell, D.
    Bhandari, M.
    Sprague, S.
    Schemitsch, E.
    BONE & JOINT OPEN, 2022, 3 (08): : 611 - 617
  • [43] POST-HOC ANALYSIS FROM A PHASE III TRIAL ASSESSING THE SAFETY AND EFFICACY OF RIX-FP IN PREVIOUSLY TREATED ADOLESCENT PATIENTS WITH HAEMOPHILIA B
    Alvarez Roman, M. T.
    Drelich, D. A.
    Seifert, W.
    Castaman, G.
    HAEMOPHILIA, 2023, 29 : 41 - 42
  • [44] Impact of galcanezumab on total pain burden: findings from phase 3 randomized, double-blind, placebo-controlled studies in patients with episodic or chronic migraine (EVOLVE-1, EVOLVE-2, and REGAIN trials)
    Ailani, Jessica
    Andrews, J. Scott
    Rettiganti, Mallikarjuna
    Nicholson, Robert A.
    JOURNAL OF HEADACHE AND PAIN, 2020, 21 (01):
  • [45] Impact of galcanezumab on total pain burden: findings from phase 3 randomized, double-blind, placebo-controlled studies in patients with episodic or chronic migraine (EVOLVE-1, EVOLVE-2, and REGAIN trials)
    Jessica Ailani
    J. Scott Andrews
    Mallikarjuna Rettiganti
    Robert A. Nicholson
    The Journal of Headache and Pain, 2020, 21
  • [46] Exploring the Effects of Ixekizumab on Pain in Patients with Ankylosing Spondylitis Based on Objective Measures of Inflammation: Post Hoc Analysis from a Large Randomized Clinical Trial
    de Vlam, Kurt
    Maksymowych, Walter P.
    Gallo, Gaia
    Rahman, Proton
    Mease, Philip
    Krishnan, Venkatesh
    McVeigh, Conor J.
    Lisse, Jeffrey
    Zhu, Danting
    Bolce, Rebecca J.
    Conaghan, Philip G.
    RHEUMATOLOGY AND THERAPY, 2024, 11 (03) : 691 - 707
  • [47] Long-term treatment with lasmiditan in patients with migraine: post hoc analysis of treatment patterns and outcomes from the open-label extension of the CENTURION randomized trial
    Komori, Mika
    Ozeki, Akichika
    Tanji, Yuka
    Kamiki, Eriko
    Krege, John H.
    Li, Lily Qian
    Suzuki, Shiho
    Shibata, Mamoru
    Takeshima, Takao
    JOURNAL OF HEADACHE AND PAIN, 2024, 25 (01):
  • [48] Cardiovascular safety of antimuscarinic add-on therapy in patients with overactive bladder who had a suboptimal response to mirabegron monotherapy: A post hoc analysis from the Japanese MILAI II study
    Katoh, Takao
    Igawa, Yasuhiko
    Yamaguchi, Osamu
    Kato, Daisuke
    Hamada, Takuya
    Kuroishi, Kentaro
    LUTS-LOWER URINARY TRACT SYMPTOMS, 2020, 12 (01) : 68 - 80
  • [49] EFFECT OF ERENUMAB ON PATIENT-REPORTED OUTCOMES IN EPISODIC MIGRAINE PATIENTS WITH PRIOR PROPHYLACTIC TREATMENT FAILURE: RESULTS FROM A POST HOC ANALYSIS OF THE STRIVE STUDY
    Pascual, J.
    Buse, D. C.
    Starling, A.
    Ailani, J.
    Zhang, F.
    Wen, S.
    Bilitou, A.
    Desai, P.
    Picard, H.
    Klatt, J.
    Mikol, D. D.
    CEPHALALGIA, 2018, 38 : 47 - 48
  • [50] 100% Response Rate to Galcanezumab in Patients With Episodic Migraine: A Post Hoc Analysis of the Results From Phase 3, Randomized, Double-Blind, Placebo-Controlled EVOLVE-1 and EVOLVE-2 Studies
    Rosen, Noah
    Pearlman, Eric
    Ruff, Dustin
    Day, Kathleen
    Nagy, Abraham Jim
    HEADACHE, 2018, 58 (09): : 1347 - 1357
12345